ASGE Annual Postgraduate Course: Clinical Challenges and Real-Time Decision Making in GI Endoscopy (On-demand) | May 2023-AbuDayyeh_Challenges encountered with balloon and ESG

AbuDayyeh_Challenges encountered with balloon and ESG

Pdf Summary

The document is a summary of a video-based lecture titled "Challenges Encountered with Balloons and ESG" delivered by Dr. Barham Abu Dayyeh, a Director of Advanced Endoscopy at Mayo Clinic. Dr. Abu Dayyeh discusses the challenges associated with using balloons and Endoscopic Sleeve Gastroplasty (ESG) in the treatment of obesity.<br /><br />The presentation highlights the unmet need for effective and durable treatments for obesity, as well as the expanding therapeutic options beyond traditional medications and diet/exercise interventions. Dr. Abu Dayyeh mentions the FDA authorization of the Apollo ESG and Revise Systems, the first FDA-authorized systems for endoscopic sleeve gastroplasty, a minimally invasive procedure for weight loss in adults with a BMI of 30-50 kg/m2 who have not been successful with more conservative measures.<br /><br />The lecture also covers Intragastric Balloon (IGB) procedures and their mechanisms of action for weight loss. Dr. Abu Dayyeh discusses baseline two-hour gastric retention and hyperinflation in IGBs, as well as the concept of adjustable IGBs.<br /><br />The document concludes with a section for questions and answers.<br /><br />Overall, the lecture provides insight into the challenges faced in the use of balloons and ESG for obesity treatment, as well as updates on the latest advancements and options for patients.

Keywords

Challenges

Balloons

ESG

obesity treatment

endoscopic sleeve gastroplasty

weight loss

FDA authorization

Apollo ESG

Revise Systems

Intragastric Balloon